发明名称 Peptides to overcome inhibition of nerve growth
摘要 Inhibition of nerve growth normally helps to prevent aberrant pathway or target selection, but also prevents needed regeneration in the mammalian central nervous system. The responsible inhibitory ligands are unknown, but pertussis toxin-sensitive G proteins, which are enriched in growth cones, appear to be involved in causing the responding growth cones to collapse. GAP-43 is an intracellular protein that can amplify the response to the stimulation of G protein-coupled receptors. We have attempted to modify the sensitivity of nerves to inhibitory signals by the use of GAP-43 peptides. The peptide corresponding to the native amino terminus sequence stimulates Go and enhances the growth cone collapse induced by inhibitory ligands. Modification of two critical cysteines generates peptides which inhibit Go and which markedly reduce the degree of inhibitor-mediated growth cone collapse.
申请公布号 AU1304895(A) 申请公布日期 1995.06.27
申请号 AU19950013048 申请日期 1994.12.07
申请人 THE GENERAL HOSPITAL CORPORATION 发明人 MARK C. FISHMAN;MICHIHIRO IGARASHI
分类号 A61K38/00;C07K14/47 主分类号 A61K38/00
代理机构 代理人
主权项
地址